Arginine/Oxytocin/Sildenafil/PT-141
L-arginine, oxytocin, sildenafil, and PT-141 (bremelanotide) are combined in this compounded troche for sexual wellness support.
- Active ingredients
- L-Arginine / Oxytocin / Sildenafil / Bremelanotide
- Form
- Troche
- Route
- Sublingual
Are you a prescriber?
Download a compounding order form for this medication with dose options and packaging choices.
FDA-approved oral sildenafil is labeled for the treatment of erectile dysfunction.1
FDA-approved bremelanotide injection is labeled for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) that causes marked distress or interpersonal difficulty, with labeled exclusions.2
Oral L-arginine supplements have been evaluated in a systematic review and meta-analysis for mild to moderate erectile dysfunction.3
FDA-approved oxytocin injection is labeled for induction of labor and related obstetric uses, not for sexual wellness.4
Those labeled uses and that arginine review apply to the individual agents. Published evidence does not establish that this four-ingredient compounded troche has been studied as a blend.
References
- U.S. Food and Drug Administration (2023). VIAGRA (sildenafil citrate) tablets - Prescribing Information. FDA Prescribing Information
- U.S. Food and Drug Administration (2025). VYLEESI (bremelanotide) injection - Prescribing Information. FDA Prescribing Information
- Rhim HC et al. (2019). The Potential Role of Arginine Supplements on Erectile Dysfunction: A Systemic Review and Meta-Analysis. The Journal of Sexual Medicine, 16, 223-234
- U.S. Food and Drug Administration (2023). PITOCIN (oxytocin) injection - Prescribing Information. FDA Prescribing Information